Francesc Bosch, MD PhD
Head of the Hematology Department at Vall d’Hebron University Hospital, Head of the Hematology Department at IOB Institute of Oncology, Professor at Universitat Autònoma de Barcelona
Barcelona, Spain
Francesc Bosch holds the position of Head of the Hematology Department at Vall d’Hebron University Hospital, as well as Head of the Hematology Department at IOB Institute of Oncology. Additionally, he serves as a Professor at the Universitat Autònoma de Barcelona.
Dr. Bosch earned his medical degree from the University of Barcelona Medical School in 1988. In 1997, he was awarded a PhD by the University of Barcelona for his research on the over-expression of Cyclin D1 in chronic lymphoproliferative disorders.
He completed a two-year postdoctoral stay at the laboratory of Professor Riccardo Dalla-Favera at the Institute of Cancer Genetics, Columbia University, New York, USA. Subsequently, he continued his research in chronic lymphocytic leukemia (CLL) at Hospital Clinic, Barcelona, starting from 2000.
In September 2009, Dr. Bosch assumed the role of Head of the Department of Hematology and Director of the Experimental Hematology Laboratory at Vall d’Hebron University Hospital in Barcelona.
Renowned for his expertise in CLL, Dr. Bosch conducts both clinical and basic research, focusing on the molecular pathogenesis of CLL and the development of innovative therapeutic strategies.
Presently, Dr. Bosch serves as the Chair of the Spanish CLL Working Group (GELLC), overseeing the development of clinical trials related to CLL in Spain. He has published more than 200 papers in peer-reviewed journals such as The New England Journal of Medicine, Nature Medicine, Cancer Cell, Blood, Journal of Clinical Oncology, and Leukemia. Additionally, he has authored or co-authored numerous reviews and book chapters on CLL and other lymphoproliferative